Delivery Order SPE2DB20D7059-SPE2DB25FQFB7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a ceiling value of $1,366.25. This firm fixed-price, non-set-aside contract is classified as a delivery order and is scheduled for completion by September 9, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a firm fixed price ceiling value of $1,270.82. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,270.82 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nalbuphine 100 mg/10 ml vials. This is a firm fixed price, non-set-aside delivery order with a completion date of August 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,488.91 delivery order to AmerisourceBergen Drug Corp for Nalbuphine 100 mg/10 mL vials, a narcotic analgesic used for pain management. The contract, awarded June 2, 2025, with completion targeted for June 3, 2025, operates under a firm fixed price structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.80 firm fixed-price delivery order is for the supply of 4567767272 ! NALBUPHINE 200 MG/10 ML VIAL 10ML, with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,824.74 firm fixed price contract is for the supply of 4564604895 - NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp, headquartered in Conshohocken, PA, is a major supplier of pharmaceutical products and...
- The Defense Logistics Agency awarded a $2,093.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone 0.4 mg/mL in vial format. The contract, which represents no set-aside designation, is scheduled for completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,943.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes. This non-set-aside contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQFB7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,906.23 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials on April 29, 2025. This competitively awarded, firm fixed-price delivery order is classified as a non-set-aside contract and carries an ultimate completion date of April 30, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical commodities to support military healthcare systems and other federal customers. The Nalbuphine delivery fulfills the ongoing pharmaceutical supply requirements under this expansive contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains in support of Defense Health Agency operations and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 4/29/25 |